STAGE III HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE III HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested as second chance for tough liver cancers
Disease control TerminatedThis study tested whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, could help control advanced liver cancer in patients whose cancer had continued to grow despite receiving the standard first-line treatment. The trial involved a small group of 15 adults…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Precision proton beams aim to zap liver tumors
Disease control TerminatedThis study tested a focused form of proton radiation therapy for adults with liver cancer. The main goal was to see if this treatment was safe for the liver and to measure how well it controlled the tumors. The trial was small and ended early, so its results are limited.
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC